首页> 外国专利> METHOD OF TREATING CANCER PREFERABLY CHARATERIZD BY EXPRESSION OF A FUSION PROTEIN COMPRISING A MEMBER OF THE E-TWENTY-SIX FAMILY BY ADMINISTERING AN AGENT THAT INHIBITS THE SYNTHESIS AND/OR ACTIVITY OF CORTISOL

METHOD OF TREATING CANCER PREFERABLY CHARATERIZD BY EXPRESSION OF A FUSION PROTEIN COMPRISING A MEMBER OF THE E-TWENTY-SIX FAMILY BY ADMINISTERING AN AGENT THAT INHIBITS THE SYNTHESIS AND/OR ACTIVITY OF CORTISOL

机译:通过表达抑制二甲醚合成和/或活性的试剂来治疗包含二十六岁家庭成员的融合蛋白来治疗癌症的方法

摘要

A method of treating a cancer selected from the group consisting of a myeloid malignancy, a lymphoid malignancy and Ewing's sarcoma is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent that inhibits the synthesis and/or activity of cortisol.
机译:公开了一种治疗癌症的方法,所述癌症选自髓系恶性肿瘤,淋巴样恶性肿瘤和尤因氏肉瘤。该方法包括向受试者施用治疗有效量的抑制皮质醇的合成和/或活性的试剂。

著录项

  • 公开/公告号WO2020105050A3

    专利类型

  • 公开/公告日2020-07-23

    原文格式PDF

  • 申请/专利权人 YEDA RESEARCH AND DEVELOPMENT CO. LTD.;

    申请/专利号WO2019IL51273

  • 发明设计人 YARDEN YOSEF;SRIVASTAVA SWATI;

    申请日2019-11-21

  • 分类号A61K31/444;A61K31/567;A61P35;

  • 国家 WO

  • 入库时间 2022-08-21 11:11:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号